CIMG Inc. (Nasdaq: IMG), a business group specializing in digital health and sales development, announced its financial results for the three months ended December 31, 2025. The company reported total revenue of $15,768,796, a substantial increase from $22,853 in the same period last year. This growth is attributed to the company's expansion into medicine-food homology products and computing power solutions, reflecting early-stage commercialization and the expansion of new business lines. Additionally, CIMG has expanded its digital asset holdings, holding 730 Bitcoins valued at approximately $63,978,821 as of December 31, 2025. The book value per share was reported at approximately $3.6, based on the number of shares outstanding at that date. The company continues to advance its transformation into the health consumer goods category and computing power technology products in the Asia market, with significant progress made in product line layout and global subsidiary establishment. CIMG's leadership emphasized a focus on expanding sales channels and improving gross profit margins while also increasing R&D investment in computing power products. The company is actively working to rectify previous listing compliance issues with Nasdaq and has filed an appeal against the delisting decision. CIMG aims to maintain its listing status while enhancing operational efficiency and driving profit growth.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.